Cervical Cancer Prevention Francisco García, MD, MPH Associate Professor Obstetrics & Gynecology Epidemiology & Biostatistics Mexican-American Studies.

Slides:



Advertisements
Similar presentations
Restructuring the Cancer Programs and Task Force Workgroups.
Advertisements

Health Disparities: Breast Cancer in African AmericansIn Lansing Health Disparities: Breast Cancer in African Americans In Lansing Costellia Talley, PhD,
Eligible Women and Participation in the Women’s Health Network Ellen M. Kramer ScD RD April 7, 2005.
Cervical Cancer. Dr. Swapna Chaudhary M.S. (MUM) Consultant Obstetrician & Gynaecologist Infertility Specialist.
Cervical Cancer DR KHALID H. WALI SAIT (FRCSC) ASSOCIATE PROFESSOR OF GYNECOLOGICAL ONCOLOGY King Abdulaziz University Hospital, Jeddah, Saudi Arabia.
Cervical Cancer American Cancer Society Georgia Department of Human Resources The University of Georgia Cooperative Extension Service.
The National Comprehensive Cancer Control Program (NCCCP): Current Progress and Future Action Temeika L. Fairley, Epidemiologist Comprehensive Cancer Control.
Gynaecological Cancers
Speaker: Decca Mohammed, MD.  Statistics for cervical cancer and HPV  Association of HPV to cervical cancer, and other cancers  Prevention  Screening.
Cancer Education and Cultural Awareness Project (CECAP)
NCI Center for Global Health Jo Anne Zujewski, M.D. September 11, 2014 Dar es Salaam, Tanzania.
New Employee Orientation
Cervical Cancer Cervical dysplasia Cervical cancer Causes Risk factors
Cervical Cancer: Molecular Impact of an Infectious Disease.
Screening for Cervical Cancer
Spotlight on Cervical Cancer Screening
OVARIAN AND CERVICAL CANCER: ARKANSAS STATISTICS Nancy Andrews Collins, M.D., MBA Associate Professor Department of Obstetrics and Gynecology College of.
Cervical Cancer: Prevention and Treatment
By: Jennifer Cox.  HPV is the most common sexually transmitted disease affecting more than 20 million people in the U.S.  HPV is responsible for 70%
Cancer Prevention in Taiwan
Cancer Program Fewer Montanans experience late stage cancer. Fewer Montanans die of cancer. Metrics Biannual percent of Montanans who are up-to-date with.
BREAST AND CERVICAL CANCER CONTROL PROGRAM Emily Vance Nursing 250.
Screening Tests for Brest & Cervical Cancer
Patient Navigation, Community Based Participatory Research and Asian Health Disparities Karen Freund MD MPH Professor and Vice Chair of Medicine Tufts.
Disparities in Cancer September 22, Introduction Despite notable advances in cancer prevention, screening, and treatment, a disproportionate number.
Breast Care for Women of Mid-Michigan (BCM) Mary Smania, MSN, FNP-BC Assistant Professor MSU College of Nursing Nurse Practitioner.
Screening for Cervical Cancer by Visual Inspection Techniques Dr Aruna Batra VMMC & SJH.
CANCER CERVIX A PREVENTABLE CANCER Dr NEETA DHABHAI Sr Consultant. – Gynaecologist Member Expert - Indian Cancer Winners’ Association
Mammography Screening Information for Providers Indian Health Service National GPRA Team.
Cervical Cancer in California Janet Bates, MD MPH Research Program Director Research and Surveillance Program California Cancer Registry.
Health Care Reform Through the Cancer Lens State and Private Sector Reforms for Hispanic Healthcare Edward E. Partridge, MD National Board President American.
Epidemiology of a Chronic Disease Exercise By Mary Murphy April 2008
Cancer Healthy Kansans 2010 Steering Committee Meeting May 12, 2005.
Community Health Needs Assessment Introduction and Overview Berwood Yost Franklin & Marshall College.
ACS MapPlace – Health Profile and Community Resources Mapping Project Carolina Casares, MD MPH Kenneth Portier, PhD.
Factors associated with abnormal PAP Smears in a health center X – Costa Rica, 2009 Leandra Abarca 1, Julia Freer 1, Maricela Salas 2 1, MD, MsC, FETP,
Report from Cervical Cancer Committee Maryland State Cancer Plan Strategies for Improving the Control of Cervical Cancer in Maryland.
Adult Medical-Surgical Nursing
Cardiovascular Disease Healthy Kansans 2010 Steering Committee Meeting April 22, 2005.
Women’s Health Disparities Among Border Populations Francisco A. R. García, MD, MPH, FACOG Distinguished Outreach Professor Public Health Obstetrics &
SUSAN G. KOMEN CENTRAL GEORGIA AFFILIATE WE LIVE HERE. WE RACE HERE. WE SAVE LIVES HERE.
Incorporating Multiple Evidence Sources for the Assessment of Breast Cancer Policies and Practices J. Jackson-Thompson, Gentry White, Missouri Cancer Registry,
Diversity and the Burden of Cancer David C. Momrow, M.P.H. Senior Vice President of Cancer Control American Cancer Society – Eastern Division January 21,
HPV and Cervical Cancer FAQ. What is cervical cancer? Cervical cancer is cancer of the cervix, the part of the uterus or womb that opens to the vagina.
Mark Clanton, M.D. M.P.H. Deputy Director Cancer Care Delivery Systems Moving Discovery Through to Delivery: A Critical Opportunity for Leadership and.
Cervical Cancer. Female Gynecologic Cancers Cervical Cancer.
Proposal by Basic Health International, Inc..  NGO founded by Dr. Miriam Cremer, MD MPH at Mount Sinai School of Medicine, New York City.  Our Vision:
Screening of genital cancers Evidence Based Presented by Dr\ Heba Nour.
GEOGRAPHIC DISTRIBUTION OF BREAST CANCER IN MISSOURI, Faustine Williams, MS., MPH, Stephen Jeanetta, Ph.D. Department of Rural Sociology, Division.
M O N T E N E G R O Negotiating Team for the Accession of Montenegro to the European Union Working Group for Chapter 28 – Consumer and Health Protection.
SCREENING IN GYNECOLOGICAL CANCER Taravat Fakheri OB/GYN KUMS.
 The Breast and Cervical Cancer Control Program N.C. Cancer Prevention and Control Branch Brittney M. Sala, BS, MPHN Candidate.
HPV-related anogenital cancers
The summary of preventive examinations- cervical cancer Agnieszka Wrzesińska, MD Project entitled „ Equal in health – prevention and early detection of.
Chapter 7: Epidemiology of Chronic Diseases. “The Change You Like to See….” (1 of 3) Chronic diseases result from prolongation of acute illness. – With.
Collaboration with Community Partners to Provide Breast and Cervical Cancer Services to the Underserved University of Texas Health Sciences Center at Tyler.
Patterns of HPV vaccination among Latinos: Key factors for consideration Rachel A. Reimer, PhD Chair Department of Public Health Director MPH program Associate.
COLLABORATION WITH COMMUNITY PARTNERS TO PROVIDE BREAST AND CERVICAL CANCER SERVICES TO THE UNDERSERVED Patti Olusola, M.D. 1, Sarah Low, M.D. 1, Michelle.
Screening Tests: A Review. Learning Objectives: 1.Understand the role of screening in the secondary prevention of disease. 2.Recognize the characteristics.
By Beshair Nurhussien, Agnes Nantambi, and Allison Wood
Cancer prevention and early detection
Need to submit travel reimbursement forms?
INTRODUCTION: CERVICAL CANCER SCREENING
Cervical Cancer in California
National Cancer Center
Cervical Cancer Surveillance, Screening, and Treatment
Oregon HPV Summit - June 2019 Nasreen Abdullah, MD, MPH
Presentation transcript:

Cervical Cancer Prevention Francisco García, MD, MPH Associate Professor Obstetrics & Gynecology Epidemiology & Biostatistics Mexican-American Studies

Objectives What is cervical cancer What causes cervical cancer How do you prevent cervical cancer

The Cervix

What is Cervical Cancer?  Most common gynecologic malignancy worldwide  US--about 10,520 new cases of invasive cervical cancer, and 3900 cancer deaths  Disproportionately affects poor women and communities of color

Global Cervical Cancer Cases

Cervical Cancer Incidence in the U.S. Incidence of cervical cancer has dramatically declined since the Pap Reprinted by permission of the American Cancer Society, Inc.

Screening Index (%) US Screening for Cervical Cancer

Cervical Cancer Life time risk 1/128 5 yr survival rate 73% Long pre-malignant disease Permits screening and early detection

US cervix cancer mortality, year rates, white females

Cervical Cancer Disproportionately affects poor women & women of color –50% in woman who never had a pap –Occurs twice as likely among Hispanics (14.8/100k v. 8.4/100k among whites) –More likely have advanced stage/invasive disease –pre-malignant disease –More likely die from cervical cancer

Cervical cancer mortality rates White Non-Hispanic Population

Cervical cancer mortality rates Black

Cervical cancer mortality rates Hispanic

AZ Cervix Cancer Mortality DIFFERENCES IN THE HEALTH STATUS AMONG ETHNIC GROUPS, ARIZONA Arizona Department of Health Services

Cancer Screening Utilization:

Percentage of Women Aged Who Had a Pap During the Preceding 3 Years, by Age Group and Education Level --- NHIS, 2005

Breast & Cervical Cancer Screening by Race, Income & Education

Trends in Recent* Pap Test Prevalence (%), by Educational Attainment and Health Insurance Status, Women 18 and Older, US, * A Pap test within the past three years. Note: Data from participating states and the District of Columbia were aggregated to represent the United States. Educational attainment is for women 25 and older. Source: Behavior Risk Factor Surveillance System CD-ROM ( , , 1998, 1999) and Public Use Data Tape (2000, 2002), National Center for Chronic Disease Prevention and Health Promotion, Center for Disease Control and Prevention,1997, 1999, 2000, 2000, 2001, Women with no health insurance Women with less than a high school education All women 18 and older

Problems with Pap Smear Screening 50-60% are due to a failure to screen 10-15% due to inappropriate follow-up 35% are errors in sampling / evaluation % = sampling error % = screening error

Histologic Classification Cervical Neoplasia Normal CIN 1--Mild dysplasia; includes condyloma CIN 2/3--Moderate/severe dysplasia/CIS Cancer--Invasive disease Normal CIN 1 (condyloma) CIN 1 (mild dys) CIN 2 (mod dys) CIN 3 (severe dysplasia/CIS) Invasive Cancer Basal cell Basal membrane

0–1 Year0–5 Years1–20 Years Invasive Cervical Cancer Cleared HPV Infection 1. Pinto AP, Crum CP. Clin Obstet Gynecol. 2000;43:352–362. CIN 1 Initial HPV Infection Continuing Infection CIN 2/3 Natural History of Cervical Cancer

Normal Nulliparous Cervix

Normal Multiparous Cervix

Pre-invasive Disease Identified through screening Pap with or w/o HPV Diagnosis made with colposcopy and biopsy Asymptomatic

Low-grade Dysplasia (CIN1)

High-grade Dysplasia (CIN 2/3)

Signs & Symptoms of Invasive Disease May be silent until advanced disease Post-coital bleeding Bloody/copious chronic vaginal discharge Abnormal bleeding during/between menses Post-menopausal bleeding Pelvic pain/pressure Unilateral leg swelling/pain Pelvic mass

Cancer

Cervical Cancer Important source of morbidity and mortality for reproductive age women Disproportionately affects minority women and poor women Preventable disease if identified during the pre malignant phase and before invasion Prevention requires access to health care and screening Also requires women to be aware of opportunities for prevention

Pima County Cervical Cancer Prevention Partnership

REACH/Pima County Cervical Cancer Prevention Partnership Women continue to fall through significant gaps in the screening, dx, and treatment safety net Disproportionately affects poor women from communities of color Many partners already addressing different aspects of the cvx ca prevention Meaningful improvement in cvx ca incidence/ mortality requires systemic coordinated effort One death from cervical cancer is one too many!

Specific Challenges Science/practice of cervical prevention advance tremendously recent years Non-industry related patient education materials/health education reflect outdated paradigm Populations most in need of information has the least access to it Prophylactic HPV vaccination makes school districts major players Health care sector may be under prepared for new screening technologies and for the vaccine based cervical cancer prevention

CDC REACH 2010 Contract Address cervical cancer prevention through community-based participatory action grounded in culture/values of Pima County Targets Mexican-American women, but not exclusive of other underserved women 5 years of funding to develop and implement a community action plan Partnership awarded 1/40 new contracts

REACH Objectives 1.Develop/disseminate a cervical cancer prevention lay community health worker training program 2.Implement school-based parent education program to facilitate HPV vaccination decision making 3.Coordinate navigator program to facilitate the diagnosis and treatment 4.Provide technical assistance to public sector entities with evidence based data to inform policy decisions surrounding implementation of HPV vaccination and new screening technologies

Vision Pima County will be a community where women do not die from cervical cancer and instead lead healthy productive lives.

Mission Increase the awareness and knowledge of cervical cancer screening, prevention, and management, as well as to facilitate access to diagnostic and treatment services.

Partners Pima County Health Department FQHCs & CHCs School Districts Community-Based Organizations Elected Officials University of Arizona –Center of Excellence in Women’s Health –University Physicians –Arizona Health Sciences Library –Arizona Cancer Center

Next Steps Community input/guidance Identifying missing stakeholders Turning ideas into actionable items Developing/implementing an action plan Monitoring progress

Preventing Cervical Cancer Informed women Educated providers Access to screening and health care Cervical cancer should be entirely preventable One cervical cancer death is one too many

Francisco Garcia, MD, MPH